Marshall Wace, LLP Avita Medical, Inc. Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$13.84 - $20.79 $167,380 - $251,434	-12,094 Reduced 47.43%	13,406 $195,000
Q2 2023 Aug 14, 2023	SELL	$10.7 - $17.48 $387,500 - $633,038	-36,215 Reduced 58.68%	25,500 $433,000
Q1 2023 May 15, 2023	SELL	$6.45 - $14.48 $11,345 - $25,470	-1,759 Reduced 2.77%	61,715 $862,000
Q4 2022 Feb 14, 2023	BUY	$4.53 - $7.55 $221,892 - $369,821	48,983 Added 338.02%	63,474 $418,000
Q3 2022 Nov 14, 2022	BUY	$4.97 - $7.89 $72,020 - $114,333	14,491 New	14,491 $77,000
Q2 2021 Aug 13, 2021	BUY	$17.23 - $22.02 $531,166 - $678,832	30,828 New	30,828 $633,000

6.01M

35.5K

38K

Ticker RCEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,030,900
Market Cap $217M
Description
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.